Leukemia L1210 Summary

Networked: 1560 relevant articles (67 outcomes, 101 trials/studies) for this Disease

Key Drugs and Agents for Leukemia L1210

1. Doxorubicin (Adriamycin) : 8 outcomes 3 studies in 71 results : FDA 12 Generic
   
2. Cyclophosphamide (Cytoxan) : 4 outcomes 6 studies in 72 results : FDA 10 Generic
   
3. Cytarabine (Cytosar-U) : 4 outcomes 5 studies in 64 results : FDA 13 Generic
   
4. Fluorouracil (Carac) : 4 outcomes 4 studies in 37 results : FDA 33 Generic
   
5. Interleukin-12 (IL 12) : 4 outcomes 4 studies in 6 results : IBA
   
6. Melphalan (Alkeran) : 3 outcomes 3 studies in 26 results : FDA 2 Generic
   
7. ambamustine : 3 outcomes 1 study in 5 results : IBA
   
8. DNA (Deoxyribonucleic Acid) : 2 outcomes 10 studies in 121 results : IBA
   
9. Methotrexate (Mexate) : 2 outcomes 8 studies in 110 results : FDA 8 Generic
   
10. Cisplatin (Platino) : 2 outcomes 6 studies in 94 results : FDA 6 Generic
    

Diseases Related to Leukemia L1210

1. Neoplasms (Cancer)
2. Experimental Melanoma
3. Lymphoma (Lymphomas)
4. Leukemia P388
5. Breast Neoplasms (Breast Cancer)

Key Therapies for Leukemia L1210

1. Heterologous Transplantation (Xenotransplantation) : 2 outcomes in 10 results
   
2. Drug Therapy (Chemotherapy) : 1 outcome 1 study in 35 results
   
3. Oral Administration : 1 outcome in 9 results
   
4. Lasers (Laser) : 1 outcome in 3 results
   
5. Homologous Transplantation (Allograft) : 3 studies in 4 results